Comparing two methods to predict ovulation outcomes in women with PCOS
Official title: Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS: A Prospective Cohort Study
Run by Cairo University · NCT06793904 · Data updated 2026-11-12
This study is testing two different methods to see which one better predicts ovulation success in women with PCOS who are trying to get pregnant.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | Women only |
| Enrollment | 122 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | January 2026 |
| Study ends | January 2026 |
| Registry record updated | February 5, 2025 |
| Trial ID | NCT06793904 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18-35 with a diagnosis of PCOS and a history of infertility lasting 1-4 years.
✕Probably not a fit
Patients with other infertility causes, chronic diseases, or contraindications to pregnancy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of two different homeostatic model assessments for insulin resistance (HOMA1-IR and HOMA2-IR) in predicting ovulation outcomes in women diagnosed with Polycystic Ovarian Syndrome (PCOS) who are seeking fertility treatment. A total of 122 participants will undergo insulin resistance assessments and will be treated with the aromatase inhibitor Letrozole to induce ovulation. Ultrasound monitoring will track follicular growth until the dominant follicle reaches the appropriate size for ovulation. The study aims to determine which assessment method provides better predictive outcomes for ovulation.
Why it matters
Potential benefit: If successful, this study could improve ovulation prediction and fertility treatment strategies for women with PCOS.
How similar studies have gone: Previous studies have shown varying success with similar approaches in assessing insulin resistance and fertility outcomes, but this specific comparison is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-35 years * duration of infertility 1-4 years * PCOS Exclusion Criteria: women with other causes of infertility (tubal factor assessed by laparoscopy or hysterosalpingogram, uterine cavity abnormality assessed by ultrasound or hysteroscopy or male factor assessed by seme analysis), * endometriosis, * ovarian cysts, * endocrinological abnormalities (Diabetes mellitus, hypothalamic, pituitary or thyroid disorders, or hyperprolactinemia), * women with history of poor ovarian response or ovarian hyperstimulation * women with chronic diseases, chromosomal, autoimmune or coagulation defects, abnormal leucocytic count or other inflammatory markers * Women with contraindications to pregnancy.
Where it's running
-
Kasr Alainy medical school
Cairo, Egypt Recruiting
Study contacts
- Principal investigator: Ahmed Maged, MD — Cairo University
- Study coordinator: Ahmed Maged, MD
- Email: dr_ahmedmaged08@kasralainy.edu.eg
- Phone: 01005227404
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can Milamend Hormone Balance help with PCOS symptoms in women
This study will see if Milamend Hormone Balance can help improve hormonal health and quality of life for women with self-reported PCOS symptoms.
-
Diaphragmatic Breathing to Improve Sleep in Women with PCOS
This study tests whether diaphragmatic breathing exercises can improve sleep quality for women with PCOS who have sleep problems.
-
Continuous glucose monitoring in PCOS
This study tests how blood sugar changes over time in adults with PCOS using a continuous glucose monitor.
-
Evaluating biomarkers for diagnosing PCOS in young women
This study is testing new blood markers to see if they can help doctors better diagnose Polycystic Ovarian Syndrome (PCOS) in young women aged 15-25.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.